Subscribe Now Subscribe Today
Short Communication
 

Langerhans Cells Could Migrate via Vein



K. Sugiura and M. Sugiura
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

The aim of this study is to investigate other route for LCs migration. Generally, Langerhans Cells (LCs) capture some antigens, then LCs migrate from the skin and present antigen to T cells in the lymph nodes. The priority route of LCs migration is via lymph vessels. If some of LCs migrates via veins, some of these cells could go to other organs, for instance, lung. We have investigated human cutaneous tissue, seborrheic keratosis by hematoxylin-eosin and immunohistochemical studying for the relation between LCs and seborrheic keratosis. We used 3-step ABC technique for CD83 and S-100 staining and LSAB technique for CD1a. We observed many s-100 and CD1a positive LCs were in the epidermis, some of these were CD83 positive cells in the vein of the dermis. One of them was passing through the valve of the vein. This was a CD83 positive cell. Present findings supported that some LCs could migrate via vein vessels. Both skin and lung have been in contact with the outside world and could have common information about antigen. Some LCs in the vein might migrate to the lung and present some information about antigens to T cells in the lung. We concluded that the route of LCs migration is not only via lymph vessels but also via the veins.

Services
Related Articles in ASCI
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

K. Sugiura and M. Sugiura, 2011. Langerhans Cells Could Migrate via Vein. Asian Journal of Dermatology, 3: 20-24.

DOI: 10.3923/ajd.2011.20.24

URL: https://scialert.net/abstract/?doi=ajd.2011.20.24
 
Received: August 13, 2010; Accepted: October 11, 2010; Published: March 28, 2011



INTRODUCTION

Dendritic cells are antigen-presenting cells in the skin and other organ tissues. Langerhans Cells (LCs) are a kind of dendritic cells derived from bone marrow in the skin. LCs plays some essential roles and LCs has close relations to allergic skin reactions, especially in the delayed hypersensitivity skin reaction. A previous report showed (Kripke et al., 1990) that Ia positive cells and FITC positive cells, some of which are LCs, leave the skin after epicutaneous sensitization and participate in the initiation of the contact hypersensitivity response in the regional lymph node. LCs migrate via lymph vessels from the skin (Sugiura et al., 2003) and then LCs present antigen-peptide to helper T cells in the lymph nodes (Sallusto and Lanzavecchia, 1999; Banchereau and Steinman, 1998). Generally, LCs in the skin is immature cells (Inaba et al., 1986) and then migrates from the skin with maturation to the lymph nodes (Yanagihara et al., 1998; Weinlich et al., 1998). Kobayashi and Hashimoto (1983) reported that LCs containing BGs migrated from dermis into the paracortical area of draining lymph nodes after injection of sterile saline in to the skin. The features of mature LCs are Birbeck Granules (Bgs). BGs are racket-shaped and rod-shaped cytoplasmic granules in the Golgi area, their functions are unknown. Kelly et al. (1978) reported that a number of large mononuclear cells with ruffled surface membranes travel from the skin, via the lymphatics, to the draining lymph node. About 3% of these cells contain BGs and isotopes labeling the majority of lymph-borne mononuclear cells were detected in the lymph node within at most 24 h in the rabbit (Kelly et al., 1978). Atypical granules show in immature LCs and atypical granules are going to turn into BGs with maturation of LCs (Mikihiro, 1970). We have ever studied about LCs in the skin tumors; in this time we observed CD1a and CD83 positive cells in the vein of the dermis. Because CD1a and CD11c positive cells were in the peripheral blood (Ito et al., 1999), it is a strong possibility that some LCs migrate from the skin via vein vessels from our results.

MATERIALS AND METHODS

This study was conducted from April 2009 to July 2010 at our clinic.

Skin: We gave informed consent to all patients in writing and obtained seborrheic keratosis by the skin surgery. We fixed them in 10% formaldehyde. We routinely processed and embedded with paraffin.

Antibody: CD1a (Immunotech, Marseilles, France), CD 83 (Biotech, Oxfordshire, UK), S-100 (DAKO Diagnostics, Humburg, Germany).

Staining: We cut skin specimens at 3 μm serially and routinely stained one serial section of these skin specimens with Hematoxylin-Eosin (HE).

Immunohistochemical studying: We prepared three serious sections for immunostaining. We used 3-step avidin-biotin complex (ABC) (Vector CA, USA) technique for CD83 staining and S-100 staining and labelled streptavidin biotin (LSAB) (Bio Genex CA, USA) technique for CD1a. Staining for CD1a was done by 3-amino-9-ethylcarbazole (AEC) and for S-100 and CD83 by 3, 3’-diaminobenzidine tetra-hydrochloride (DAB).

RESULTS AND DISCUSSION

We observed some s-100 and CD1a positive cells with dendritic pattern in the vein of the dermis. One of them was passing through the valve of the vein. This was a CD83 positive cell (Fig. 1).

Langerhans Cells (LCs) play important roles in immune cutaneous, thymus, lung and lymph nodes systems. The epidermis of 4-5% is composed by LCs. We observed CD1a LCs in the vein by immunohistochemical studying. It is necessary to confirm why a CD1a and CD83 positive LC was in the vein. We guessed three reasons: the first is that they are presenting antigen to the T lymphocytes in the vein, second is that they are presenting information about antigens to the lung immune systems and third is wrong migration. There were some reports about Airborne Contact Dermatitis (ACD) (Bonamonte et al., 2002; Patiwael et al., 2005). Respiratory symptoms after skin prick test and pollen allergy causing skin irritation were common findings. These symptoms were often caused at a different site to the one where the antigens were introduced. It is our hypothesis that some LCs in the veins could be one causative factor in the ACD and these symptoms. Previously some investigators studied CD1a positive LCs in the lung by immunohistochemical method (Fox et al., 1989; Coli et al., 1990).

Image for - Langerhans Cells Could Migrate via Vein
Fig. 1: Upper side, HE staining of the skin, original magnification x100 Middle side, CD1a staining of the skin, original magnification x100 Lower side, CD83 staining of the skin, original magnification x100

It is a possibility that some LCs migrate from the skin to other organs, especially lung and present common information about the antigens to the immune systems. We assured the above mentioned first and second reasons for CD1a and CD83 (+) cells in the vein to be true. Migration of LCs was induced by some chemokines (Zaitseva et al., 1997; Sato et al., 1999; Dieu et al., 1998) and cytokines (Heufler et al., 1988; Cumberbatch et al., 1997; Roake et al., 1995). It is unknown that what kinds of chemokine caused migration via vein, but same cytokines and chemokines would play roles in migration via vein. Complements are important signals for allergic hypersensitivity, interaction between mast cells and dendritic cells (Jawdat et al., 2004). Mast cells induce LCs migration through mast cell derived signals and histamine (Caron et al., 2001a, b; Jawdat et al., 2004) and IgE mediated mast cell activation induced Lcs migration (Jawdat et al., 2004). Because there were many mast cells, H2 receptors and a lot of histamine in the vein, these could be related with LCs migration via vein. Our conclusion was that the process and route for LCs migration from the skin may not only be via lymph vessels, but also via veins.

REFERENCES

  1. Banchereau, J. and R.M. Steinman, 1998. Dendritic cells and the control of immunity. Nature, 392: 245-252.
    CrossRef  |  PubMed  |  


  2. Bonamonte, D., M. Carino, L. Mundo and C. Foti, 2002. Occupational airborne allergic contact dermatitis from 2-aminothiophenol. Eur. J. Dermatol., 12: 592-593.
    PubMed  |  Direct Link  |  


  3. Caron, G., Y. Delneste, E. Roelandts, C. Duez, J.Y. Bonnefoy, J. Pestel and P. Jeannin, 2001. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol., 167: 3682-3686.
    PubMed  |  


  4. Caron, G., Y. Delneste, E. Roelandts, C. Duez and N. Herbault et al., 2001. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J. Immunol., 166: 6000-6006.
    PubMed  |  


  5. Coli, A., G. Bigotti and T. Cione, 1990. Langerhans cell and HLA class molecules distribution in lung carcinoma. J. Nucl. Med. Allied Sci., 34: 185-189.
    PubMed  |  


  6. Cumberbatch, M., R.J. Dearman and I. Kimber, 1997. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology, 92: 388-395.
    PubMed  |  


  7. Dieu, M.C., B. Vanbervliet, A. Vicari, J.M. Bridon and E. Oldham et al., 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med., 188: 373-386.
    PubMed  |  


  8. Fox, S.B., M. Jones, M.S. Dunnill, K.C. Gatter and D.Y. Mason, 1989. Langerhans cells in human lung tumours: An immunohistologica study. Histopathology, 14: 269-275.
    PubMed  |  Direct Link  |  


  9. Heufler, C., F. Koch and G. Schuler, 1988. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med., 167: 700-705.
    PubMed  |  


  10. Inaba, K., G. Schuler, M.D. Witmer, J. Valinksy, B. Atassi and R.M. Steinman, 1986. Immunologic properties of purified epidermal langerhans cells: Distinct requirements for stimulation of unprimed and sensitized Tlymphocytes. J. Exp. Med., 164: 605-613.
    PubMed  |  


  11. Ito, T., K. Inaba, J. Toki, S. Sogo and T. Iguchi et al., 1999. A CD1a+/CD11c+subset of human blood dendritic cells is a direct precursor of langerhans cells. J. Immunol., 163: 1409-1419.
    PubMed  |  


  12. Jawdat, D.M., E.J. Albert, G. Rowden, I.D. Haidl and J.S. Marshall, 2004. IgE-mediated mast cell activation induces langerhans cell migration in vivo. J. Immunol., 173: 5275-5282.
    PubMed  |  


  13. Kelly, R.H., B.M. Balfour, J.A. Armstrong and S. Griffiths, 1978. Functional anatomy of lymph nodes: Peripheral lymph-borne mononuclear cells. Anatomical Record, 190: 5-22.
    PubMed  |  


  14. Kobayashi, M. and M. Hashimoto, 1983. Distribution of cored tuble-containing langerhans cells in the skin and lymph nodes of mice. J. Electron. Microscopy, 32: 197-206.
    PubMed  |  


  15. Kripke, M.L., C.G. Munn, A. Jeevan, J.M. Tang and C. Bucana, 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes sensitization. J. Immunol., 145: 2833-2838.
    PubMed  |  


  16. Mikihiro, S., 1970. Langerhans cell granule in letterer-siwe disease. An electron microscopic study. Cancer, 26: 1102-1108.
    PubMed  |  


  17. Patiwael, J.A., M. Wintzen, T. Rustemeyer and D.P. Bruynzeel, 2005. Airborne irritant contact dermatitis due to synthetic fibres from an air-conditioning filter. Contact Dermatitis, 52: 126-129.
    PubMed  |  


  18. Roake, J.A., A.S. Rao, P.J. Morris, C.P. Larsen, D.F. Hankins and J.M. Austyn, 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor and interleukin 1. J. Exp. Med., 181: 2237-2247.
    PubMed  |  


  19. Sato, K., H. Kawasaki, H. Nagayama, R. Serizawa and J. Ikeda et al., 1999. CC chemokine receptors, CCR-1 and CCR-3 are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells. Blood, 93: 34-42.
    PubMed  |  


  20. Sallusto, F. and A. Lanzavecchia, 1999. Mobilizing dendritic cells for tolerance, priming and chronic inflammation. J. Exp. Med., 189: 611-614.
    PubMed  |  


  21. Sugiura, K., M. Shamoto, N. Sakamoto, M. Shinzato and A. Osada et al., 2003. It is true that, when langerhans cells migrate from the skin to the lymph node, they are transported via lymph vessels. Dermatology, 206: 222-224.
    PubMed  |  


  22. Weinlich, G., M. Heine, H. Stossel, M. Zanella and P. Stoitzner et al., 1998. Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J. Inv. Dermatol., 110: 441-449.
    CrossRef  |  PubMed  |  


  23. Yanagihara, S., E. Komura, J. Nagafune, H. Watarai and Y. Yamaguchi, 1998. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol., 161: 3096-3102.
    PubMed  |  


  24. Zaitseva, M., A. Blauvelt, S. Lee, C.K. Lapham and V. Klaus-Kovtun et al., 1997. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection. Nat. Med., 3: 1369-1375.
    CrossRef  |  PubMed  |  


©  2022 Science Alert. All Rights Reserved